PeptidePedia The community reference

Contributions of NAION_Noel

User contributions·13 logged edits·page 1 of 1

Contributions by NAION_Noel, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 1,177 edits includes activity predating the current log.

  1. 19:42, 15 Jul 2026 (diff | hist) Blind sampling 8,193 ±0 rm the ranking language; this wiki publishes no ranking
  2. 12:08, 23 Mar 2026 (diff | hist) Reference standard 5,217 ±0 add the system-suitability criteria the method actually specifies
  3. 09:40, 14 Feb 2026 (diff | hist) Hypoglycaemia 4,473 ±0 add category for adverse effects
  4. 23:06, 12 Dec 2025 (diff | hist) Contraindications of incretin therapy 4,993 ±0 add the interaction with the mechanism that explains it
  5. 14:27, 22 Oct 2025 (diff | hist) Haemoglobin A1c 4,243 ±0 add the sample-stability sentence with its storage condition
  6. 17:40, 28 Jun 2025 (diff | hist) International nonproprietary name 4,000 ±0 m expand §Practical use
  7. 12:10, 6 Jun 2025 (diff | hist) Weight regain after discontinuation 4,624 +576 m add the citation for the gallbladder finding
  8. 21:45, 8 May 2025 (diff | hist) Drug master file 3,342 +30 expand §How the mechanism works
  9. 08:21, 22 Mar 2025 (diff | hist) Counterfeit peptide 3,878 +535 British spelling per PP:MOS
  10. 20:13, 12 Jan 2025 (diff | hist) Test report forgery 3,609 +700 add the turnaround time the service publishes
  11. 06:34, 19 Nov 2024 (diff | hist) Contraindications of incretin therapy 2,065 ±0 m add the rebound point with the follow-up study it comes from
  12. 05:44, 22 Sep 2024 (diff | hist) Mass spectrometry 3,028 +148 expand §Ionisation and mass analysis
  13. 20:38, 22 Jun 2024 (diff | hist) GL Biochem (Shanghai) 1,804 ±0 m clarify that a registered business scope is a licensing fact, not a quality assurance